14.39p+0.39 (+2.79%)14 Feb 2025, 16:09
Find out how to deal online from £1.50 in a SIPP, ISA or Dealing account.AJ Bell logo
Jump to:

Futura Medical PLC Fundamentals

Company NameFutura Medical PLCLast Updated2025-02-14
IndustryBiotechnologySectorHealthcare
Shares in Issue303.830 mMarket Cap£43.72 m
PE Ratio0.00Dividend per Share0
Dividend Yield0Dividend Cover0
EPS-£0.02EPS Growth (%)0
PEG0DPS Growth (%)0
Debt Ratio0Debt Equity Ratio0
Asset Equity Ratio1.2122Cash Equity Ratio0.5020
Quick Ratio3.3226Current Ratio3.75
Price To Book Value5.5991ROCE0

Futura Medical PLC Dividends

TypeEx-DatePay DateCurrencyNet DividendYear Total

Futura Medical PLC Company Financials

Assets20232022
Tangible Assets£2.48 m£1.16 m
Intangible Assets00
Investments00
Total Fixed Assets£2.48 m£1.16 m
Stocks£339.000
Debtors£1.15 m£70,114.00
Cash & Equivalents£7.71 m£4.03 m
Other Assets00
Total Assets£11.82 m£6.47 m
Liabilities20232022
Creditors within 1 year£6.34 m£1.75 m
Creditors after 1 year00
Other Liabilities00
Total Liabilities£6.34 m£1.75 m
Net assets£5.48 m£4.72 m
Equity20232022
Called up share capital£602,812.00£576,093.00
Share Premium£71.07 m£66.55 m
Profit / Loss-£6.89 m-£6.87 m
Other Equity£5.48 m£4.72 m
Preference & Minorities00
Total Capital Employed£5.48 m£4.72 m
Ratios20232022
Debt Ratio00
Debt-to-Equity00
Assets / Equity1.21221.2122
Cash / Equity0.50200.5020
EPS-£0.02-£0.02
Cash Flow20232022
Cash from operating activities£570,253.00-£5.78 m
Cashflow before financing£5.12 m-£5.61 m
Increase in Cash£3.69 m-£6.35 m
Income20232022
Turnover£3.10 m0
Cost of sales£1.33 m0
Gross Profit£1.77 m0
Operating Profit-£6.96 m-£6.87 m
Pre-Tax profit-£6.89 m-£6.87 m

Futura Medical PLC Company Background

SectorHealthcare
ActivitiesFutura Medical PLC is engaged in the development and commercialization of sexual health products. Its product Eroxon is a treatment for erectile dysfunction. Geographically, the company derives a majority of its revenue from the United Kingdom and the European Union.
Latest Interim Date10 Sep 2024
Latest Fiscal Year End Date10 Apr 2024

Futura Medical PLC Directors

AppointedNamePosition
2025-01-13Mr. Jeffrey Robert NeedhamNon-Executive Director,Chairman
2023-07-18Mr. John Milne ClarkeNon-Executive Director,Chairman
2016-03-31Ms. Lisa Arnold Non-Executive Director
2012-02-01Dr. William Duncan PotterExecutive Director,Chairman
2025-01-13Mr. Andrew Vaughan UnittNon-Executive Director,Senior Independent Director
2024-09-13Mr. James Henry BarderExecutive Director,Chief Executive
2021-12-29Mr. Jonathan David Freeman Non-Executive Director,Senior Independent Director
2015-03-28Mr. David Bryn DaviesExecutive Director,Chief Development Officer
2018-04-09Mr. Derek Adrian MartinExecutive Director,Finance Director and Company Secretary
2011-08-09Mr. Anthony Louis Clayden BSc,FCA,MSIExecutive Director,Finance Director and Company Secretary
2024-09-13Mr. Kenneth William JamesExecutive Director,Head of RandD
2024-04-29Ms. Angela HildrethExecutive Director,Finance Director, Chief Operating Officer and Company Secretary
2025-01-13Mr. Gordon Roy DavisNon-Executive Director

Futura Medical PLC Contact Details

Company NameFutura Medical PLC
Address40 Occam Road, Surrey Technology Centre, Guildford, GU2 7YG
Telephone+44 1483685670
Websitehttps://www.futuramedical.com

Futura Medical PLC Advisors

AuditorKPMG
Phone+44 1189642000
Fax+44 1189642222
BankHSBC Bank PLC
SolicitorWithers & Rogers LLP
Phone+44 2079403600
Fax+44 2073789680
StockbrokerN+1 Singer
Phone+44 2074963000
Fax+44 2074963150
Nominated AdviserN+1 Singer
Phone+44 2074963000
Fax+44 2074963150
RegistrarCapita Asset Services
Phone+44 8716640300
Fax+44 2086392342
Financial PR AdviserBuchanan
Phone+44 2074665000
Fax+44 2074665001
SolicitorMemery Crystal
Phone+44 2072425905
Fax+44 2072422058